At the European Association for the Study of Diabetes meeting, Louis J. Aronne, MD, argued that obesity medications could make bariatric surgery obsolete, thanks to drugs that treat multiple metabolic conditions. Francesco Rubino, MD, countered, suggesting “metabolic” surgery will continue to play a key role, especially for long-term management of obesity and related conditions. Aronne believes future treatments will address obesity earlier, while Rubino sees surgery remaining important for certain patients. Both agree obesity management is evolving rapidly.
Trending
- Are we sleepwalking into AI disruption in GI?
- AI Digital Twins Are Helping People Manage Diabetes and Obesity (WIRED)
- 3 Healthcare Threats That Will Soon Become Too Big To Solve (Forbes)
- From GLP-1s to engineered probiotics: New research highlights evolving IBD care (AGA)
- Physician consolidation squeeze: Rising costs and tight cash flow are reshaping practice growth (Physicians Practice)
- The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of gut health (Nature Reviews Gastroenterology & Hepatology)
- Medical Malpractice: Staying Out of Trouble (GI & Endoscopy News)
- Evaluating Benefits of AI During Colonoscopy (GI & Endoscopy News)
